-
501
Revisiting the Link Between HLA‐DRB1 Alleles and Autoantibodies in Rheumatoid Arthritis: Association of non‐Shared Epitope Alleles *09 and *15 With High Levels of Anti–Citrullinated Peptide/Protein Antibodies
Published 2025-01-01“…We focused on a quantitative analysis of the levels of anti–cyclic citrullinated peptide IgG antibodies, including those falling below the diagnostic threshold. …”
Get full text
Article -
502
A new peptide inhibitor of C1QBP exhibits potent anti‐tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair
Published 2025-01-01Subjects: “…anti‐tumour peptide…”
Get full text
Article -
503
The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF)
Published 2025-02-01“…Endothelial dysfunction is a significant component of HFpEF pathophysiology, and glucagon-like peptide-1 receptor (GLP-1R) agonists have shown potential benefits in improving endothelial function. …”
Get full text
Article -
504
Recombinant Human Brain Natriuretic Peptide Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting CD4+ T Cell Proliferation via PI3K/AKT/mTOR Pathway Activation
Published 2020-01-01“…Recombinant human brain natriuretic peptide (rhBNP), a man-made version of a peptide that is elevated in heart failure, exhibits anti-inflammatory effects in various tissues. …”
Get full text
Article -
505
Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction
Published 2021-01-01“…The aim was to investigate (1) whether liraglutide therapy could improve B-type natriuretic peptide (BNP) levels and diastolic cardiac function assessed by the E-wave to E′ ratio (E/E′) using transthoracic echocardiography (TTE), and (2) whether E/E′ contributed to BNP improvement independent of bodyweight reduction (UMIN000005565). …”
Get full text
Article -
506
Current and Novel Therapies for Cluster Headache: A Narrative Review
Published 2024-11-01Subjects: “…Calcitonin gene-related peptide monoclonal antibodies…”
Get full text
Article -
507
-
508
-
509
Computational design of drug candidates for influenza A virus subtype H1N1 by inhibiting the viral neuraminidase-1 enzyme
Published 2014-06-01Subjects: Get full text
Article -
510
-
511
68Ga-NOTA-RM26 PET/CT in the evaluation of glioma: a pilot prospective study
Published 2025-01-01Subjects: Get full text
Article -
512
Relationship Between Obstructive Sleep Apnea and Enuresis in Children: Current Perspectives and Beyond
Published 2025-02-01Subjects: Get full text
Article -
513
Evaluation of allergenic protein profiles in three Chinese high-oleic acid peanut cultivars using NanoLC-Orbitrap mass spectrometry
Published 2023-05-01Subjects: Get full text
Article -
514
Nutrients regulation of skin cells from canines and cats via Wnt/β-catenin signaling pathway
Published 2025-02-01Subjects: Get full text
Article -
515
Preparation and Characteristics of Acid-soluble Soybean Protein Hydrolysates
Published 2025-02-01Subjects: Get full text
Article -
516
Bifidobacterium animalis subsp. lactis TG11 ameliorates loperamide-induced constipation in mice by modulating gut microbiota
Published 2025-01-01Subjects: Get full text
Article -
517
Systematic functional analysis and potential application of a serine protease from cold-adapted Planococcus bacterium
Published 2023-09-01Subjects: Get full text
Article -
518
-
519
A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated Chickens
Published 2013-01-01“…We have constructed a live bacterial vaccine against avian influenza by expressing a conserved peptide from the ectodomain of M2 antigen (M2e) on the surface of Lactococcus lactis (LL). …”
Get full text
Article -
520
Is Weight Loss the Main Driver for A1C Improvement by Glucagon‐Like Peptide 1 (GLP‐1) Receptor Agonists? A 2.5‐Year Analysis in Real‐World Clinical Practice
Published 2025-01-01“…ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are established treatment options for type 2 diabetes (T2D). …”
Get full text
Article